Statins and liver injury.
作者信息
Thapar Manish, Russo Mark W, Bonkovsky Herbert L
机构信息
Department of Medicine, Drexel University College of Medicine, Philadelphia, Pennsylvania;
Department of Medicine, Carolinas HealthCare System and the University of North Carolina School of Medicine, Charlotte, North Carolina.
出版信息
Gastroenterol Hepatol (N Y). 2013 Sep;9(9):605-6.
Abstract
摘要
相似文献
1
Statins and liver injury.他汀类药物与肝损伤。
Gastroenterol Hepatol (N Y). 2013 Sep;9(9):605-6.
2
Hepatotoxicity of statins and other lipid-lowering agents.他汀类药物和其他降脂药物的肝毒性。
Liver Int. 2017 Feb;37(2):173-178. doi: 10.1111/liv.13308. Epub 2016 Nov 27.
3
[Association between statins use and liver injury based on prescription sequence symmetry analysis].基于处方序列对称性分析的他汀类药物使用与肝损伤之间的关联
Zhonghua Liu Xing Bing Xue Za Zhi. 2016 Jul;37(7):935-9. doi: 10.3760/cma.j.issn.0254-6450.2016.07.006.
4
The Use of Statins in Patients With Chronic Liver Disease and Cirrhosis.他汀类药物在慢性肝病和肝硬化患者中的应用。
Curr Treat Options Gastroenterol. 2018 Jun;16(2):226-240. doi: 10.1007/s11938-018-0180-4.
5
Liver function tests and statins.肝功能检查与他汀类药物
Curr Opin Cardiol. 2011 Jul;26(4):338-41. doi: 10.1097/HCO.0b013e328347036f.
6
Statins and its hepatic effects: Newer data, implications, and changing recommendations.他汀类药物及其肝脏效应：新数据、影响及推荐的变化
J Pharm Bioallied Sci. 2016 Jan-Mar;8(1):23-8. doi: 10.4103/0975-7406.171699.
7
Addition of statins to the standard treatment in patients with cirrhosis: Safety and efficacy.在肝硬化患者的标准治疗中添加他汀类药物：安全性和疗效。
World J Gastroenterol. 2021 Jul 28;27(28):4639-4652. doi: 10.3748/wjg.v27.i28.4639.
8
Use of Statins in Patients with Chronic Liver Disease and Cirrhosis: Current Views and Prospects.他汀类药物在慢性肝病和肝硬化患者中的应用：当前观点与前景
Curr Gastroenterol Rep. 2017 Sep;19(9):43. doi: 10.1007/s11894-017-0584-7.
9
Use of multiple international healthcare databases for the detection of rare drug-associated outcomes: a pharmacoepidemiological programme comparing rosuvastatin with other marketed statins.利用多个国际医疗保健数据库检测罕见药物相关结局：一项比较瑞舒伐他汀与其他市售他汀类药物的药物流行病学研究计划。
Pharmacoepidemiol Drug Saf. 2010 Dec;19(12):1218-24. doi: 10.1002/pds.2032. Epub 2010 Oct 4.
10
Prescription of statins to dyslipidemic patients affected by liver diseases: a subtle balance between risks and benefits.给患有肝脏疾病的血脂异常患者开具他汀类药物处方：风险与获益之间的微妙平衡。
Nutr Metab Cardiovasc Dis. 2004 Aug;14(4):215-24. doi: 10.1016/s0939-4753(04)80008-5.
引用本文的文献
1
Simultaneous Occurrence of Wilson's Disease, Autoimmune Hepatitis, and Hereditary Hemochromatosis: A Diagnostic Challenge.威尔逊病、自身免疫性肝炎和遗传性血色素沉着症同时发生：诊断难题
Middle East J Dig Dis. 2024 Jan;16(1):64-68. doi: 10.34172/mejdd.2024.371. Epub 2024 Jan 31.
2
MicroRNA-206 as a potential cholesterol-lowering drug is superior to statins in mice.miR-206 作为一种有潜力的降胆固醇药物，在降低胆固醇方面优于他汀类药物。
J Lipid Res. 2024 Jul;65(7):100576. doi: 10.1016/j.jlr.2024.100576. Epub 2024 Jun 10.
3
Association of De Ritis Ratio with Prognosis in Patients with Coronary Artery Disease and Aminotransferase Activity within and outside the Healthy Values of Reference Range.冠心病患者中德瑞蒂斯比值与预后以及参考范围健康值内外转氨酶活性的关联
J Clin Med. 2023 Apr 28;12(9):3174. doi: 10.3390/jcm12093174.
4
The Benefits Outweigh the Risks of Treating Hypercholesterolemia: The Statin Dilemma.治疗高胆固醇血症利大于弊：他汀类药物困境
Cureus. 2023 Jan 11;15(1):e33648. doi: 10.7759/cureus.33648. eCollection 2023 Jan.
5
Statin-induced Liver Injury Patterns: A Clinical Review.他汀类药物所致肝损伤模式：一项临床综述
J Clin Transl Hepatol. 2022 Jun 28;10(3):543-552. doi: 10.14218/JCTH.2021.00271. Epub 2022 Jan 10.
6
Effect of liver total sphingomyelin synthase deficiency on plasma lipid metabolism.肝总鞘磷脂合成酶缺乏对血浆脂质代谢的影响。
Biochim Biophys Acta Mol Cell Biol Lipids. 2021 May;1866(5):158898. doi: 10.1016/j.bbalip.2021.158898. Epub 2021 Feb 2.
7
Comparison of pleiotropic effects of statins vs fibrates on laboratory parameters in patients with dyslipidemia: A retrospective cohort study.比较他汀类药物与贝特类药物对血脂异常患者实验室参数的多效作用：一项回顾性队列研究。
Medicine (Baltimore). 2020 Dec 11;99(50):e23427. doi: 10.1097/MD.0000000000023427.
8
Cannabidiol and Abnormal Liver Chemistries in Healthy Adults: Results of a Phase I Clinical Trial.大麻二酚对健康成年人肝生化指标的影响：一项 I 期临床试验结果。
Clin Pharmacol Ther. 2021 May;109(5):1224-1231. doi: 10.1002/cpt.2071. Epub 2020 Nov 21.
9
Comparison of Lipid Profile, Liver Enzymes, Creatine Kinase and Lactate Dehydrogenase Among Type II Diabetes Mellitus Patients on Statin Therapy.他汀类药物治疗的2型糖尿病患者血脂谱、肝酶、肌酸激酶和乳酸脱氢酶的比较
Diabetes Metab Syndr Obes. 2020 Mar 18;13:763-773. doi: 10.2147/DMSO.S234382. eCollection 2020.
10
Randomized controlled trial comparing the efficacy of daily and every other day atorvastatin therapy and its correlation with serum hydroxymethylglutaryl-CoA reductase enzyme levels in naïve dyslipidemic patients.一项随机对照试验，比较初治血脂异常患者每日及隔日服用阿托伐他汀治疗的疗效及其与血清羟甲基戊二酰辅酶A还原酶水平的相关性。
Indian Heart J. 2018 Dec;70 Suppl 3(Suppl 3):S64-S67. doi: 10.1016/j.ihj.2018.05.010. Epub 2018 May 26.
本文引用的文献
1
Statin-induced cholestatic hepatitis: confirmed on rechallenge.他汀类药物引起的胆汁淤积性肝炎：再激发试验确诊。
Gastroenterol Hepatol (N Y). 2013 Sep;9(9):603-5.
2
Statins and primary liver cancer: a meta-analysis of observational studies.他汀类药物与原发性肝癌：观察性研究的荟萃分析。
Eur J Cancer Prev. 2013 May;22(3):229-34. doi: 10.1097/CEJ.0b013e328358761a.
3
Statins and colorectal cancer.他汀类药物与结直肠癌。
Clin Gastroenterol Hepatol. 2013 Feb;11(2):109-18; quiz e13-4. doi: 10.1016/j.cgh.2012.08.037. Epub 2012 Sep 12.
4
Atorvastatin correlates with decreased risk of esophageal cancer: a population-based case-control study from Taiwan.阿托伐他汀与食管癌风险降低相关：来自中国台湾的一项基于人群的病例对照研究。
Libyan J Med. 2012;7. doi: 10.3402/ljm.v7i0.18830. Epub 2012 Aug 9.
5
Acute hepatitis E infection accounts for some cases of suspected drug-induced liver injury.急性戊型肝炎感染可导致部分疑似药物性肝损伤病例。
Gastroenterology. 2011 Nov;141(5):1665-72.e1-9. doi: 10.1053/j.gastro.2011.07.051. Epub 2011 Aug 16.
6
Statins are associated with a reduced risk of gastric cancer: a population-based case-control study.他汀类药物与胃癌风险降低相关：一项基于人群的病例对照研究。
Am J Gastroenterol. 2011 Dec;106(12):2098-103. doi: 10.1038/ajg.2011.277. Epub 2011 Aug 16.
7
Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis.在希腊阿托伐他汀和冠心病评估（GREACE）研究中，对于有冠心病和肝功能异常的患者，长期他汀类药物治疗对心血管事件的安全性和有效性：一项事后分析。
Lancet. 2010 Dec 4;376(9756):1916-22. doi: 10.1016/S0140-6736(10)61272-X. Epub 2010 Nov 23.
8
Statin therapy improves sustained virologic response among diabetic patients with chronic hepatitis C.他汀类药物治疗可改善糖尿病合并慢性丙型肝炎患者的持续病毒学应答。
Gastroenterology. 2011 Jan;140(1):144-52. doi: 10.1053/j.gastro.2010.08.055. Epub 2010 Sep 15.
9
Serum cholesterol and statin use predict virological response to peginterferon and ribavirin therapy.血清胆固醇和他汀类药物的使用预测聚乙二醇干扰素和利巴韦林治疗的病毒学应答。
Hepatology. 2010 Sep;52(3):864-74. doi: 10.1002/hep.23787.
10
Drug-induced liver injury associated with statins.与他汀类药物相关的药物性肝损伤。
Semin Liver Dis. 2009 Nov;29(4):412-22. doi: 10.1055/s-0029-1240010. Epub 2009 Oct 13.
Zotero 插件